In a significant shift in the global pharmaceutical landscape, a substantial portion of French medicines is now being ...

Japanese pharmaceutical company Takeda inaugurated its first Innovation Capability Centre (ICC) in Bengaluru, marking its debut in Asia. The ICC aims to employ 750 professionals, including software ...

each containing 320 mg of BIMZELX The single-injection device offers convenience for patients requiring a 320 mg dose of BIMZELX with single-injection administration (PRNewsfoto/UCB, Inc.) With ...

SAN FRANCISCO, Jan 16 (Reuters) - The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for president-elect Donald Trump and Congress on ...

As I step into Rajeev Juneja’s office at Mankind Pharma’s Delhi headquarters, the wall in front of me immediately commands attention. It features a collection of iconic quotes and striking ...

The growing investment in India's CDMO sector indicates confidence in India’s pharmaceutical sector and its potential - A detailed analysis. With the U.S. increasingly adopting an anti-China ...

Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

France starts 2025 with a further drawdown of its military presence in its former African colonies, and fresh tensions ignited this week with controversial remarks by French President Emmanuel ...

Jan 11 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Saturday that it entered into a partnership with Denmark's LEO Pharma to develop programs to treat patients with inflammatory ...

Alliance Pharma has agreed to a £349.7 million pound takeover by DBAY Advisors, its biggest shareholder. The deal would see shareholders get 62.5p per share, representing a 41% uplift on Alliance ...

UCB, listed on Euronext Brussels, generated revenue of 5.3 billion euros ($5.7 billion) in 2023. The company focuses on therapies for severe diseases of the immune and central nervous systems. All the ...

UCB, a global biopharmaceutical company ... XtalFold has been licensed to multiple global pharmaceutical companies and has delivered impactful results in a variety of projects, including antigen ...